UPDATE: UBS Upgrades Mallinckrodt (MNK) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Mallinckrodt (MNK) PT Lifted at Piper Jaffray Amid Questcor Deal
April 8, 2014 7:55 AM EDTPiper Jaffray analyst David Amsellem reiterated an Overweight rating on Mallinckrodt plc (NYSE: MNK) and bumped his price target from $87 to $90 following the acquisition of Questcor (NASDAQ: QCOR), saying.despite fears Acthar cash flows are sustainable
Amsellem... More
Jefferies Downgrades Questcor Pharmaceuticals (QCOR) to Hold Following Takeover
April 8, 2014 6:58 AM EDTJefferies downgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Buy to Hold with a price target of $86.00 after the sale to Mallinckrodt plc (NYSE: MNK) for $30 per share in cash plus 0.897 MNK share. The downgrade comes as they see limited... More
BMO Capital Upgrades Mallinckrodt (MNK) to Outperform
April 8, 2014 6:49 AM EDTBMO Capital upgraded Mallinckrodt (NYSE: MNK) from Market Perform to Outperform with a price target of $71.00 (from $70.00).
For an analyst ratings summary and ratings history on Mallinckrodt plc click here. For more ratings news on Mallinckrodt plc click here.
Shares of Mallinckrodt plc closed at $60.95 yesterday.
... MoreJefferies Maintains Buy on Mallinckrodt plc (MNK) Post Questcor Bid
April 8, 2014 6:48 AM EDTJefferies analyst Anthony Petrone reiterated a Buy rating and $77 price target on Mallinckrodt plc (NYSE: MNK) following the company's Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) acquisition.
Petrone said, "MNK made a... More
Mallinckrodt (MNK) to Acquire Questcor Pharma (QCOR) in $5.6B Deal
April 7, 2014 7:02 AM EDTMallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceuticals company, and Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), a high-growth biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which Mallinckrodt will acquire Questcor in a transaction valued at approximately $5.6 billion. The transaction was unanimously approved by the Boards of Directors of both companies. Subject to customary closing conditions, the transaction is currently expected to be completed in the third calendar quarter of 2014.
Under the terms of the transaction, Questcor shareholders will receive $30.00... More
